Every person with Parkinson’s disease (PD) experiences a unique journey – some people’s symptoms progress slowly over many years, while others may develop severe disabilities within a shorter time.

In her paper "Trust and Trustworthiness in AI Ethics," Karoline Reinhardt discusses the growing conversation about trust in artificial intelligence, as AI becomes more common in the society around us.

Parkinson’s disease (PD) is one of the most common neurological disorders, affecting around 10 million worldwide. It is a chronic, progressive disease. With advances in treatment, people with PD today often live long and active lives despite their diagnosis.

The paper "A.I. Robustness: A Human-Centered Perspective on Technological Challenges and Opportunities," written by Andrea Tocchetti and his colleagues, looks at different challenges in ensuring the reliability and safety of artificial intelligence systems.

Getting an accurate diagnosis of Parkinson’s disease (PD) can be a long journey. PD is a progressive neurological disorder with no single definitive lab test, so doctors rely on clinical evaluation of symptoms. #mAI-Health

The AI-PROGNOSIS project explores the critical impact of sex and gender on Parkinson’s disease (PD), aiming to enhance diagnostic and treatment approaches by considering these important factors.